Success Stories: Our Efficient Response to the RFE Propelled a Postdoctoral Research Associate with 60 Citations in the Field of Molecular Biology to EB-1A Success

Client’s Testimonial:

“Congrats to your team too. This could never have been possible without your help and guidance. I am really happy for all what you did to make my case presentable and answer me back on each and every question in a very timely manner. I have experienced an unmatched professional service with best quality.”

On September 7^th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Postdoctoral Research Associate

Country of Origin: India

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Missouri

Approval Notice Date: September 7^th, 2016

Processing Time: 6 months, 15 days (Premium Processing Requested)

Case Summary:

North America Immigration Law Group (WeGreened.com) recently helped a postdoctoral research associate from India get his EB-1A (Alien of Extraordinary Ability) petition approved. Together, our legal team and support staff worked diligently to prove to the USCIS that our client’s presence in the United States is distinctly advantageous to the nation. For one, his investigations on the development and elucidation of biomarkers of pancreatic and kidney disease, as well as therapeutic targets for treatment of liver and kidney fibrosis have given American healthcare professionals the tools they need to better treat patients at earlier stages of disease development.

With 60 citations and 38 instances of peer review under his belt as well as 10 published articles to his name, our client met the requirements to file his I-140 petition under EB-1A. To strengthen his case, we incorporated other relevant information into his petition packet such as his doctoral degree, his CV, evidence of his employment at the time of filing, as well as seven recommendation letters. These letters were contributed by other influential molecular biologists, all of whom agreed to lend their support for our client’s EB-1A petition. From a senior scientist in Zurich to a professor in Melbourne, our client’s supporters were made up of researchers based all around the world. This in itself is evidence of the fact that our client’s work progresses the field as a whole and not just the work of researchers based in the US. According to one of his recommenders: “[Client’s] studies are vital to satisfying modern day health care needs around the globe regarding the detection and treatment of this ailment. His research in the development of biomarkers is both highly specialized and demanded. [Client] has achieved a level of accomplishment that is largely unmatched.” Besides supporting evidence such as those listed above, our client’s petition packet also listed the various reasons why his work is crucial to the US and how stopping his research in the country would be detrimental to the nation.

Despite our strong presentation of our client’s solid credentials, the USCIS issued a Request for Evidence (RFE). Less than two months after we received notification of the RFE, we submitted our response to the USCIS. Our convincing reply persuaded them to approve our client’s EB-1A petition, proving yet again that we will do what it takes to help our clients get one step closer to their green cards. We congratulate our client on this milestone and wish him the best as he adjusts his status for permanent residence.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.